14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CLRB ranks #16025 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cellectar Biosciences Stock Forecast NASDAQ:CLRB

$0.90 (-2.24%)

Volume: 320k

Closed: Oct 22, 2021

Hollow Logo Score: -4.931

Cellectar Biosciences Stock Forecast

$0.90 (-2.24%)

Volume: 320k

Closed: Oct 22, 2021

Score Hollow Logo -4.931

Cellectar Biosciences Stock Price (Quote) NASDAQ:CLRB

$0.90 ( -2.24% ) Friday, 22nd Oct 2021

Range Low Price High Price Comment
30 days $0.83 $1.01 Friday, 22nd Oct 2021 CLRB stock ended at $0.90. This is 2.24% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 5.34% from a day low at $0.87 to a day high of $0.92.
90 days $0.81 $1.15
52 weeks $0.81 $2.98

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
2021-10-22 $0.91 $0.92 $0.87 $0.90 319 941
2021-10-21 $0.94 $0.95 $0.92 $0.92 119 815
2021-10-20 $0.92 $0.96 $0.90 $0.93 227 021
2021-10-19 $0.89 $0.91 $0.87 $0.91 237 330
2021-10-18 $0.90 $0.92 $0.88 $0.91 138 457
2021-10-15 $0.91 $0.98 $0.91 $0.92 294 349
2021-10-14 $0.92 $0.93 $0.90 $0.91 101 398
2021-10-13 $0.91 $0.93 $0.89 $0.92 176 169
2021-10-12 $0.86 $0.98 $0.85 $0.92 409 016
2021-10-11 $0.85 $0.86 $0.83 $0.84 341 912
2021-10-08 $0.87 $0.88 $0.83 $0.85 434 306
2021-10-07 $0.86 $0.87 $0.84 $0.85 356 137
2021-10-06 $0.87 $0.88 $0.85 $0.85 181 920
2021-10-05 $0.86 $0.88 $0.85 $0.86 208 456
2021-10-04 $0.91 $0.92 $0.86 $0.87 278 900
2021-10-01 $0.91 $0.92 $0.89 $0.91 440 091
2021-09-30 $0.91 $0.93 $0.91 $0.93 205 914
2021-09-29 $0.97 $0.97 $0.90 $0.91 282 297
2021-09-28 $0.99 $0.99 $0.96 $0.96 198 316
2021-09-27 $1.00 $1.00 $0.98 $0.99 119 560
2021-09-24 $0.97 $1.01 $0.97 $0.98 319 409
2021-09-23 $0.96 $0.98 $0.96 $0.98 352 456
2021-09-22 $0.98 $1.00 $0.97 $0.98 374 155
2021-09-21 $0.98 $0.99 $0.96 $0.96 184 050
2021-09-20 $0.98 $1.01 $0.96 $0.97 399 356
2021-09-17 $0.98 $1.02 $0.97 $1.01 301 454
2021-09-16 $0.99 $1.01 $0.97 $0.99 206 683
2021-09-15 $1.05 $1.05 $0.97 $0.98 526 257
2021-09-14 $1.04 $1.05 $1.01 $1.04 306 494
2021-09-13 $1.05 $1.05 $1.00 $1.02 301 559
2021-09-10 $1.02 $1.05 $1.00 $1.04 641 975
2021-09-09 $1.02 $1.02 $0.99 $1.01 414 748
2021-09-08 $1.05 $1.06 $0.96 $1.01 827 130
2021-09-07 $1.04 $1.06 $1.02 $1.04 1 288 121
2021-09-03 $1.04 $1.05 $1.02 $1.03 431 904
2021-09-02 $1.04 $1.09 $1.02 $1.03 496 118
2021-09-01 $1.02 $1.06 $1.01 $1.06 914 459
2021-08-31 $0.95 $1.02 $0.95 $1.02 572 472
2021-08-30 $0.96 $0.98 $0.95 $0.95 185 340
2021-08-27 $0.97 $1.00 $0.93 $0.97 496 949
2021-08-26 $0.97 $0.99 $0.94 $0.97 225 909
2021-08-25 $0.93 $0.99 $0.92 $0.97 378 192
2021-08-24 $0.88 $0.96 $0.88 $0.94 896 679
2021-08-23 $0.82 $0.90 $0.82 $0.88 1 113 955
2021-08-20 $0.84 $0.86 $0.81 $0.82 1 394 354
2021-08-19 $0.84 $0.87 $0.82 $0.82 1 271 428
2021-08-18 $0.88 $0.89 $0.85 $0.87 1 429 834
2021-08-17 $0.87 $0.91 $0.85 $0.88 653 521
2021-08-16 $0.87 $0.93 $0.85 $0.90 1 617 535
2021-08-13 $0.86 $0.88 $0.84 $0.87 947 484

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, engages in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate and is currently being evaluated in a Phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT